RCI-605

N/A

Report date: 2024/07/05 17:38:12

Base Information

Drug NameRCI-605
Drug Alias NameRCI-605RCI605
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionVanilloid receptor antagonists
TargetsTransient receptor potential cation channel subfamily V member 1
Therapy Area/IndicationsShort Rib-Polydactyly Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRudacure Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRudacure Co Ltd
Inactive CompaniesN/A
Active IndicationsShort Rib-Polydactyly Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A